Page
%P
-
Article
Open AccessThe Janus face of endogenous neuronal tPA: promoting self-protection and worsening the death of neighboring neurons
Recombinant tissue-type plasminogen activator (r-tPA/Actilyse) stands as the prevailing pharmacological solution for treating ischemic stroke patients, of whom because their endogenous circulating tPA alone is...